(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WUXIAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

WUXIAN

ST13

US500000090192433

Class

40

Filing

90192433

Registration

6634503

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

05/19/2022

Trademark type

Combined

Nice classes

40

Filing date

09/18/2020

Registration date

02/01/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/01/2022

Last transaction

02/01/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2017-10-00

First use in commerce

2017-10-00

Drawing code

3

Owner type

99

Owner location

DUNDALK, COUNTY LOUTH, IE

Examiner

DUBRAY, KATHERINE M

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "WuXian" in black with the letter "X" in blue and green with two black non-Latin characters over the "AN" with a thick yellow horizontal line extending out from one leg of the "X" to the end of the word.

Holders and representatives

Holders

WUXI BIOLOGICS IRELAND LIMITED
WuXi Biologics Co., Ltd.

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP

Technical classification

Nice Classes

Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Biomanufacturing for othersmanufacturing of biopharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacturing services for others in the field of biopharmaceuticals

Publications

History of USPTO decisions and trademark events.

25 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/19/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

02/01/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/29/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/28/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/16/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/13/2021

IUAF

USE AMENDMENT FILED

11/12/2021

EISU

TEAS STATEMENT OF USE RECEIVED

11/12/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/22/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/27/2021

PUBO

PUBLISHED FOR OPPOSITION

04/27/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/07/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/18/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

02/25/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/25/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/25/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/25/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

02/25/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/03/2021

GNRT

NON-FINAL ACTION E-MAILED

02/03/2021

CNRT

NON-FINAL ACTION WRITTEN

02/03/2021

DOCK

ASSIGNED TO EXAMINER

01/27/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/28/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/27/2020

NWAP

NEW APPLICATION ENTERED

09/22/2020

Continuous trademark protection

Get notified about every new filing that threatens WUXIAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.